S01LA Antineovascularisation agents
ATC class of level 4 – chemical subgroup
This page lists the patient medication information or the product monograph for 18 drugs in this drug class and its subclasses.
- 18 prescription (Rx)
Place in the ATC system
- S Sensory organ drugs 335 drugs
- S01 Ophthalmologicals 324 drugs
- S01L Ocular vascular disorder agents 18 drugs
-
S01LA Antineovascularisation agents 18 drugs
- S01LA01 Verteporfin 1 drug
- S01LA03 Pegaptanib 1 drug
- S01LA04 Ranibizumab 5 drugs
- S01LA05 Aflibercept 9 drugs
- S01LA06 Brolucizumab 1 drug
- S01LA09 Faricimab 1 drug
-
S01LA Antineovascularisation agents 18 drugs
- S01L Ocular vascular disorder agents 18 drugs
- S01 Ophthalmologicals 324 drugs
Active ingredients of the class
- Aflibercept 9 drugs
- Brolucizumab 1 drug
- Faricimab 1 drug
- Pegaptanib 1 drug
- Ranibizumab 5 drugs
- Verteporfin 1 drug
Drugs in the class and its subclasses
| Drug | Rx or OTC |
|---|---|
| Aflivu PM (S01LA05 Aflibercept) | prescription (Rx) |
| Ahzantive PM (S01LA05 Aflibercept) | prescription (Rx) |
| Beovu PM (S01LA06 Brolucizumab) | prescription (Rx) |
| Enzeevu PM (S01LA05 Aflibercept) | prescription (Rx) |
| Eydenzelt (S01LA05 Aflibercept) | prescription (Rx) |
| Eylea PM (S01LA05 Aflibercept) | prescription (Rx) |
| Eylea Hd PM (S01LA05 Aflibercept) | prescription (Rx) |
| Lucentis (S01LA04 Ranibizumab) | prescription (Rx) |
| Macugen (S01LA03 Pegaptanib) | prescription (Rx) |
| Melvizo PM (S01LA04 Ranibizumab) | prescription (Rx) |
| Opuviz PM (S01LA05 Aflibercept) | prescription (Rx) |
| Pavblu PM (S01LA05 Aflibercept) | prescription (Rx) |
| Ranopto (S01LA04 Ranibizumab) | prescription (Rx) |
| Ranvu (S01LA04 Ranibizumab) | prescription (Rx) |
| Susvimo PM (S01LA04 Ranibizumab) | prescription (Rx) |
| Vabysmo PM (S01LA09 Faricimab) | prescription (Rx) |
| Visudyne (S01LA01 Verteporfin) | prescription (Rx) |
| Yesafili PM (S01LA05 Aflibercept) | prescription (Rx) |
Other names of the drug class
- Czech: S01LA Látky určené k léčbě neovaskularizace v oblasti oka
- English (United Kingdom): S01LA Antineovascularisation agents
- French: S01LA médicaments contre la néo-vascularisation oculaire
- German: S01LA Antineovaskuläre Mittel
- German (Austria): S01LA Antineovaskuläre Mittel
- Italian: S01LA Sostanze antineovascolarizzanti
- Polish: S01LA Substancje do leczenia neowaskularyzacji w oku
- Turkish: S01LA Antineovaskülarizasyon ajanları
- Portuguese (Brazil): S01LA Fármacos antineovascularização
- German (Switzerland): S01LA Antineovaskuläre Mittel
- French (Switzerland): S01LA Médicaments contre la néo-vascularisation oculaire
- Italian (Switzerland): S01LA Sostanze antineovascolarizzanti
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class S01LA
Ask your doctor or pharmacist for advice.